Using genes to facilitate the endogenous repair and regeneration of orthopaedic tissues

International Orthopaedics

Volumn 38, Issue 9, 2014, Pages 1761-1769

  Evans, Christopher ^a,b  

^a MAYO CLINIC   (United States)

^b AO FOUNDATION   (Switzerland)

Author keywords

Arthritis; Bone; Cartilage; Facilitated endogenous repair; Gene therapy; Regenerative orthopaedics

Indexed keywords

ALLOGRAFT; ARTICULAR CARTILAGE; BIOPSY; BONE TISSUE; CARTILAGE CELL; CELL ISOLATION; CELL MANIPULATION; CELLS; DONOR CELL; GENE EXPRESSION; GENE PRODUCT; GENE TARGETING; GENE THERAPY; GENE VECTOR; HUMAN; IN VIVO GENE TRANSFER; NONHUMAN; PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; REIMPLANTATION; REVIEW; TISSUE ENGINEERING; TISSUE IMPLANT; TISSUE REPAIR; VETERINARY MEDICINE; ANIMAL; BIOLOGICAL THERAPY; BONE DISEASES; BONE REGENERATION; DISEASE MODEL; GENE TRANSFER; PROCEDURES; TRENDS;

ANIMALS; BONE DISEASES; BONE REGENERATION; CELL- AND TISSUE-BASED THERAPY; DISEASE MODELS, ANIMAL; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS;

EID: 84922833426     PISSN: 03412695     EISSN: 14325195     Source Type: Journal    
DOI: 10.1007/s00264-014-2423-x     Document Type: Review

References (70)

1. Evans CH (2013) Advances in regenerative orthopedics. Mayo Clin Proc 88(11):1323-39
2. Evans CH, Robbins PD (1999) Genetically augmented tissue engineering of the musculoskeletal system. Clinical orthopaedics and related research. (367 Suppl):S410-8.
3. Evans CH, Ghivizzani SC, The RPD (2003) Nicolas Andry Award. Orthop Genet Ther Clin Orthop Relat Res 2004(429):316-29
4. Evans CH, Robbins PD (1995) Possible orthopaedic applications of gene therapy. J bone Joint Surg Am Vol 77(7):1103-14
5. Evans CH, Palmer GD, Pascher A, Porter R, Kwong FN, Gouze E et al (2007) Facilitated endogenous repair: making tissue engineering simple, practical, and economical. Tissue Eng 13(8):1987-93
6. Sohier J, Moroni L, van Blitterswijk C, de Groot K, Bezemer JM (2008) Critical factors in the design of growth factor releasing scaffolds for cartilage tissue engineering. Expert Opin Drug Deliv 5(5):543-66
7. Moutsatsos IK, Turgeman G, Zhou S, Kurkalli BG, Pelled G, Tzur L et al (2001) Exogenously regulated stem cell-mediated gene therapy for bone regeneration. Mol Ther: J Am Soc Gene Ther 3(4):449-61
8. Kimelman-Bleich N, Pelled G, Sheyn D, Kallai I, Zilberman Y, Mizrahi O et al (2009) The use of a synthetic oxygen carrier-enriched hydrogel to enhance mesenchymal stem cell-based bone formation in vivo. Biomaterials 30(27):4639-48
9. Vannucci L, Lai M, Chiuppesi F, Ceccherini-Nelli L, Pistello M (2013) Viral vectors: a look back and ahead on gene transfer technology. New Microbiol 36(1):1-22
10. Ginn SL, Alexander IE, Edelstein ML, Abedi MR, Wixon J (2013) Gene therapy clinical trials worldwide to 2012 - an update. J Gene Med 15(2):65-77
11. Wang W, Li W, Ma N, Steinhoff G (2013) Non-viral gene delivery methods. Curr Pharm Biotechnol 14(1):46-60
12. Lin CY, Lu CH, Luo WY, Chang YH, Sung LY, Chiu HY et al (2010) Baculovirus as a gene delivery vector for cartilage and bone tissue engineering. Curr Gene Ther 10(3):242-54
13. Lattermann C, Baltzer AW, Zelle BA, Whalen JD, Niyibizi C, Robbins PD et al (2004) Feasibility of percutaneous gene transfer to an atrophic nonunion in a rabbit. Clin Orthop Relat Res 425:237-43
14. Niyibizi C, Baltzer A, Lattermann C, Oyama M, Whalen JD, Robbins PD et al (1998) Potential role for gene therapy in the enhancement of fracture healing. Clinical orthopaedics and related research. (355 Suppl):S148-53.
15. Betz OB, Betz VM, Nazarian A, Egermann M, Gerstenfeld LC, Einhorn TA et al (2007) Delayed administration of adenoviral BMP-2 vector improves the formation of bone in osseous defects. Gene Ther 14(13):1039-44
16. Betz VM, Betz OB, Glatt V, Gerstenfeld LC, Einhorn TA, Bouxsein ML et al (2007) Healing of segmental bone defects by direct percutaneous gene delivery: effect of vector dose. Hum Gene Ther 18(10):907-15
17. Betz OB, Betz VM, Nazarian A, Pilapil CG, Vrahas MS, Bouxsein ML et al (2006) Direct percutaneous gene delivery to enhance healing of segmental bone defects. J Bone Joint Surg Am Vol 88(2):355-65
18. Southwood LL, Frisbie DD, Kawcak CE, Ghivizzani SC, Evans CH, McIlwraith CW (2004) Evaluation of Ad-BMP-2 for enhancing fracture healing in an infected defect fracture rabbit model. J Orthop Res: Off Publ Orthop Res Soc 22(1):66-72
19. Baltzer AW, Lattermann C, Whalen JD, Braunstein S, Robbins PD, Evans CH (1999) A gene therapy approach to accelerating bone healing. Evaluation of gene expression in a New Zealandwhite rabbit model. Knee Surg Sports Traumatol Arthrosc: Off J ESSKA 7(3):197-202
20. Baltzer AW, Lattermann C, Whalen JD, Wooley P, Weiss K, Grimm M et al (2000) Genetic enhancement of fracture repair: healing of an experimental segmental defect by adenoviral transfer of the BMP-2 gene. Gene Ther 7(9):734-9
21. Baltzer AW, Lattermann C, Whalen JD, Ghivizzani S, Wooley P, Krauspe R et al (2000) Potential role of direct adenoviral gene transfer in enhancing fracture repair. Clinical orthopaedics and related research. (379 Suppl):S120-5.
22. Bertone AL, Pittman DD, Bouxsein ML, Li J, Clancy B, Seeherman HJ (2004) Adenoviral-mediated transfer of human BMP-6 gene accelerates healing in a rabbit ulnar osteotomy model. J Orthop Res: Off Publ Orthop Res Soc 22(6):1261-70
23. Menendez MI, Clark DJ, Carlton M, Flanigan DC, Jia G, Sammet S et al (2011) Direct delayed human adenoviral BMP-2 or BMP-6 gene therapy for bone and cartilage regeneration in a pony osteochondral model. Osteoarthr Cartil / OARS, Osteoarthr Res Soc 19(8):1066-75
24. Ishihara A, Zekas LJ, Weisbrode SE, Bertone AL (2010) Comparative efficacy of dermal fibroblast-mediated and direct adenoviral bone morphogenetic protein-2 gene therapy for bone regeneration in an equine rib model. Gene Ther 17(6):733-44
25. Ishihara A, Shields KM, Litsky AS, Mattoon JS, Weisbrode SE, Bartlett JS et al (2008) Osteogenic gene regulation and relative acceleration of healing by adenoviral-mediated transfer of human BMP-2 or -6 in equine osteotomy and ostectomy models. J Orthop Res: Off Publ Orthop Res Soc 26(6):764-71
26. Egermann M, Baltzer AW, Adamaszek S, Evans C, Robbins P, Schneider E et al (2006) Direct adenoviral transfer of bone morphogenetic protein-2 cDNA enhances fracture healing in osteoporotic sheep. Hum Gene Ther 17(5):507-17
27. Egermann M, Lill CA, Griesbeck K, Evans CH, Robbins PD, Schneider E et al (2006) Effect of BMP-2 gene transfer on bone healing in sheep. Gene Ther 13(17):1290-9
28. Cucchiarini M, Madry H (2005) Gene therapy for cartilage defects. J Gene Med 7(12):1495-509
29. Cucchiarini M, Madry H, Ma C, Thurn T, Zurakowski D, Menger MD et al (2005) Improved tissue repair in articular cartilage defects in vivo by rAAV-mediated overexpression of human fibroblast growth factor 2. Mol Ther:J Am Soc Gene Ther 12(2):229-38
30. Madry H, Cucchiarini M, Terwilliger EF, Trippel SB (2003) Recombinant adeno-associated virus vectors efficiently and persistently transduce chondrocytes in normal and osteoarthritic human articular cartilage. Hum Gene Ther 14(4):393-402
31. Watson RS, Broome TA, Levings PP, Rice BL, Kay JD, Smith AD (2013) scAAV-mediated gene transfer of interleukin-1-receptor antagonist to synovium and articular cartilage in large mammalian joints. Gene Ther 20(6):670-7
32. Madry H, Cucchiarini M, Kaul G, Kohn D, Terwilliger EF, Trippel SB (2004) Menisci are efficiently transduced by recombinant adeno-associated virus vectors in vitro and in vivo. Am J Sports Med 32(8):1860-5
33. Goto H, Shuler FD, Lamsam C, Moller HD, Niyibizi C, Fu FH et al (1999) Transfer of lacZ marker gene to the meniscus. J Bone Joint Surg Am Vol 81(7):918-25
34. Nishida K, Kang JD, Suh JK, Robbins PD, Evans CH, Gilbertson LG (1998) Adenovirus-mediated gene transfer to nucleus pulposus cells. Implications Treat Intervertebral Disc Degener Spine 23(22):2437-42, discussion 43
35. Leckie SK, Bechara BP, Hartman RA, Sowa GA, Woods BI, Coelho JP et al (2012) Injection of AAV2-BMP2 and AAV2-TIMP1 into the nucleus pulposus slows the course of intervertebral disc degeneration in an in vivo rabbit model. Spine J: Off J N Am Spine Soc 12(1):7-20
36. Ren S, Liu Y, Ma J, Liu Y, Diao Z, Yang D et al (2013) Treatment of rabbit intervertebral disc degeneration with co-transfection by adeno-associated virus-mediated SOX9 and osteogenic protein-1 double genes in vivo. Int J Mol Med 32(5):1063-8
37. Le Maitre CL, Hoyland JA, Freemont AJ (2007) Interleukin-1 receptor antagonist delivered directly and by gene therapy inhibits matrix degradation in the intact degenerate human intervertebral disc: an in situ zymographic and gene therapy study. Arthritis Res Ther 9(4):R83
38. Evans C (2006) Potential biologic therapies for the intervertebral disc. J Bone Joint Surg Am Vol 88(Suppl 2):95-8
39. Evans CH, Ghivizzani SC, Robbins PD (2013) Arthritis gene therapy and its tortuous path into the clinic. Transl Res:J Lab Clin Med 161(4):205-16
40. Hildebrand KA, Frank CB, Hart DA (2004) Gene intervention in ligament and tendon: current status, challenges, future directions. Gene Ther 11(4):368-78
41. Docheva D, Mueller S, Majewski M, Evans CH (2014) Biologics for tendon repair. Advanced drug delivery reviews. ;In Press.
42. Kang R, Marui T, Ghivizzani SC, Nita IM, Georgescu HI, Suh JK et al (1997) Ex vivo gene transfer to chondrocytes in full-thickness articular cartilage defects: a feasibility study. Osteoarthr Cartil / OARS, Osteoarthr Res Soc 5(2):139-43
43. Baragi VM, Renkiewicz RR, Qiu L, Brammer D, Riley JM, Sigler RE et al (1997) Transplantation of adenovirally transduced allogeneic chondrocytes into articular cartilage defects in vivo. Osteoarthr Cartil / OARS, Osteoarthr Res Soc 5(4):275-82
44. Brower-Toland BD, Saxer RA, Goodrich LR, Mi Z, Robbins PD, Evans CH et al (2001) Direct adenovirus-mediated insulin-like growth factor I gene transfer enhances transplant chondrocyte function. Hum Gene Ther 12(2):117-29
45. Goodrich LR, Hidaka C, Robbins PD, Evans CH, Nixon AJ (2007) Genetic modification of chondrocytes with insulin-like growth factor-1 enhances cartilage healing in an equine model. J Bone Joint Surg British Vol 89(5):672-85
46. Nixon AJ, Brower-Toland BD, Bent SJ, Saxer RA, Wilke MJ, Robbins PD et al (2000) Insulinlike growth factor-I gene therapy applications for cartilage repair. Clinical orthopaedics and related research. (379 Suppl):S201-13.
47. Madry H, Kaul G, Zurakowski D, Vunjak-Novakovic G, Cucchiarini M (2013) Cartilage constructs engineered from chondrocytes overexpressing IGF-I improve the repair of osteochondral defects in a rabbit model. Eur Cells Mater 25:229-47
48. Orth P, Kaul G, Cucchiarini M, Zurakowski D, Menger MD, Kohn D et al (2011) Transplanted articular chondrocytes co-overexpressing IGF-I and FGF-2 stimulate cartilage repair in vivo. Knee Surg Sports Traumatol Arthrosc:Off J ESSKA 19(12):2119-30
49. Che JH, Zhang ZR, Li GZ, Tan WH, Bai XD, Qu FJ (2010) Application of tissue-engineered cartilage with BMP-7 gene to repair knee joint cartilage injury in rabbits. Knee Surg Sports Traumatol Arthrosc:Off J ESSKA 18(4):496-503
50. Hidaka C, Goodrich LR, Chen CT, Warren RF, Crystal RG, Nixon AJ (2003) Acceleration of cartilage repair by genetically modified chondrocytes over expressing bone morphogenetic protein-7. J Orthop Res: Off Publ Orthop Res Soc 21(4):573-83
51. Ha CW, Noh MJ, Choi KB, Lee KH (2012) Initial phase I safety of retrovirally transduced human chondrocytes expressing transforming growth factor-beta-1 in degenerative arthritis patients. Cytotherapy 14(2):247-56
52. Lieberman JR, Daluiski A, Stevenson S, Wu L, McAllister P, Lee YP et al (1999) The effect of regional gene therapy with bone morphogenetic protein-2-producing bone-marrow cells on the repair of segmental femoral defects in rats. J Bone Joint Surg Am Vol 81(7):905-17
53. Lieberman JR, Le LQ, Wu L, Finerman GA, Berk A, Witte ON et al (1998) Regional gene therapy with a BMP-2-producing murine stromal cell line induces heterotopic and orthotopic bone formation in rodents. J Orthop Res: Off Publ Orthop Res Soc 16(3):330-9
54. Tsuchida H, Hashimoto J, Crawford E, Manske P, Lou J (2003) Engineered allogeneic mesenchymal stem cells repair femoral segmental defect in rats. J Orthop Res: Off Publ Orthop Res Soc 21(1):44-53
55. Sonnet C, Simpson CL, Olabisi RM, Sullivan K, Lazard Z, Gugala Z et al (2013) Rapid healing of femoral defects in rats with low dose sustained BMP2 expression from PEGDA hydrogel microspheres. J Orthop Res: Off Publ Orthop Res Soc 31(10):1597-604
56. Virk MS, Sugiyama O, Park SH, Gambhir SS, Adams DJ, Drissi H et al (2011) "Same day" ex-vivo regional gene therapy: a novel strategy to enhance bone repair. Mol Ther:J Am Soc Gene Ther 19(5):960-8
57. Schinhan M, Mueller AM, Liu F, Shen Z, Porter RM, Windhager R et al (2012) Fibrin-encapsulated, genetically modified adipose-derived stem cells for use in tissue repair (abstract). J Tissue Eng Regen Med 6:265
58. Shore EM, Xu M, Feldman GJ, Fenstermacher DA, Cho TJ, Choi IH et al (2006) A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva. Nat Genet 38(5):525-7
59. Forsberg JA, Pepek JM, Wagner S, Wilson K, Flint J, Andersen RC et al (2009) Heterotopic ossification in high-energy wartime extremity injuries: prevalence and risk factors. J Bone Joint Surg Am Vol 91(5):1084-91
60. Zeckey C, Hildebrand F, Frink M, Krettek C (2011) Heterotopic ossifications following implant surgery-epidemiology, therapeutical approaches and current concepts. Semin Immunopathol 33(3):273-86
61. Evans CH, Liu FJ, Glatt V, Hoyland JA, Kirker-Head C, Walsh A et al (2009) Use of genetically modified muscle and fat grafts to repair defects in bone and cartilage. Eur Cells Mat 18:96-111
62. Pascher A, Palmer GD, Steinert A, Oligino T, Gouze E, Gouze JN et al (2004) Gene delivery to cartilage defects using coagulated bone marrow aspirate. Gene Ther 11(2):133-41
63. Neumann AJ, Schroeder J, Alini M, Archer CW, Stoddart MJ (2013) Enhanced adenovirus transduction of hMSCs using 3D hydrogel cell carriers. Mol Biotechnol 53(2):207-16
64. Ivkovic A, Pascher A, Hudetz D, Maticic D, Jelic M, Dickinson S et al (2010) Articular cartilage repair by genetically modified bone marrow aspirate in sheep. Gene Ther 17(6):779-89
65. Evans CH, Ghivizzani SC, Robbins PD (2012) Orthopedic gene therapy-lost in translation? J Cell Physiol 227(2):416-20
66. Buning H (2013) Gene therapy enters the pharma market: the short story of a long journey. EMBO Mol Med 5(1):1-3
67. Wehling P, Reinecke J, Baltzer AW, Granrath M, Schulitz KP, Schultz C et al (2009) Clinical responses to gene therapy in joints of two subjects with rheumatoid arthritis. Hum Gene Ther 20(2):97-101
68. Evans CH, Robbins PD, Ghivizzani SC, Wasko MC, Tomaino MM, Kang R et al (2005) Gene transfer to human joints: progress toward a gene therapy of arthritis. Proc Natl Acad Sci U S A 102(24):8698-703
69. Mease PJ, Hobbs K, Chalmers A, El-Gabalawy H, Bookman A, Keystone E et al (2009) Local delivery of a recombinant adenoassociated vector containing a tumour necrosis factor alpha antagonist gene in inflammatory arthritis: a phase 1 dose-escalation safety and tolerability study. Ann Rheum Dis 68(8):1247-54
70. Mease PJ, Wei N, Fudman EJ, Kivitz AJ, Schechtman J, Trapp RG et al (2010) Safety, tolerability, and clinical outcomes after intraarticular injection of a recombinant adeno-associated vector containing a tumor necrosis factor antagonist gene: results of a phase 1/2 Study. J Rheumatol 37(4):692-703